Introduction
Exogenous pyrogens such as bacterial endotoxin (lipopolysaccharide, LPS) initiate a complex host response which includes fever, neutrophilia and changes in circulating glucocorticoid, glycoproteins and serum metal levels, collectively called the acutephase reaction (APR). It is thought that LPS-induced APR is caused by the release of cytokines into circulation by several cell types including macrophages, endothelial cells and fibroblasts. Many of these cytokines, including interleukin-1 (IL-1), interleukin-6 (IL-6), tumour necrosis factor (TNF), interleukin-8 (IL-8) and macrophage inflammatory protein-1 (MIP-1), generally known as endogenous pyrogens (EP) can induce fever when injected into experimental animals and humans (see Reference 1 for a review). Although all endogenous pyrogens can induce fever the real role of each in the febrile response is not clearly established. It has been suggested that IL-1 (largely IL-I) is a primary mediator of fever since peripheral or central injection of this cytokine induces fever in different species. [2] [3] [4] In addition, antiserum to IL-I prevents the increase in body temperature and plasma IL-6 activity induced by intraperitoneal (i.p.) injections of LPS in rats. However, there is little data demonstrating an elevation of IL-I[ in the plasma of febrile animals and no increase in this cytokine was detected in the cerebrospinal fluid of cats or in the hypothalamus of rats after peripheral injection of A. R. Zampronio et al. hypothalamus of rats was observed by using doses of endotoxin that in terms of fever induction are supra-maximal. 8 Recent studies in guinea-pigs and rats have shown an increase in intrahypothalamic concentrations of IL-6-and TNF-like activity during LPS-induced fever. In spite of a strong correlation between plasma IL-6 activity and increase in the body temperature in guinea-pigs, there was no correlation between fever and plasma TNF, or between fever and IL-6 or TNF in the hypothalamic perfusate. In rats, the hypothalamic infusion of IL-6, but not TNF, at a rate that would mimic the amount of cytokine activity found in the anterior hypothalamus during LPS-induced fever, was effective in inducing an increase in body temperature.
Data from many studies suggest that the first cytokine to increase in plasma after LPS injection in different animal species is TNF 9-11 but its role in fever is still unresolved. Intravenous infusions of TNF in humans, or bolus injection of this cytokine in rats and other species, result in fever. 4 ,1,1-1 Furthermore, pre-treatment of rabbits with antiserum to TNF inhibits LPS-induced fever. 5 However, recent studies attribute to TNF the role of an endogenous cryogen, rather than an endogenous pyrogen, since antiserum to TNF has been shown to increase LPS-induced fever in rats. [16] [17] [18] [19] Interleukin-8 is a cytokine released by a wide variety of cell types upon exposure to inflammatory stimuli or endogenous mediators such as IL-1 and TNF'-' and has been shown to induce fever after central administration in rats. Unlike the response to other cytokines, the febrile response induced by IL-8 is not dependent on prostaglandin synthesis. ',' Macrophages represent one of the main sources of known cytokines 's and have also been shown to release a chemotactic factor that specifically induces neutrophil migration. 6 This chemotactic substance, macrophage-released neutrophil chemotactic factor (MNCF), is released by rat peritoneal macrophages following a brief in vitro stimulation with heterologous serum, LPS, TNF(z or IL-I. Cytokine assays: Cytokine bioactivities were measured in supernatants from Dex-treated macrophages and control supernatants. For these studies, the supernatant was lyophilized and resuspended in culture medium. IL-1 was assayed as described previously, using the D10(N4)M (D10) cell line. 34 Activity was determined by comparison to the National Institute of Biological Standards and Controls (NIBSC) interim standard for IL-I (lot. 86.552, 1 U 10 pg).
IL-6 was assayed using the B9 hybridoma 5'6 as described previously by Holt et al. 7 For the assay, B9 cells were used 3-4 days after the last subculture.
Bioactivity was determined by comparison to a recombinant IL-6 preparation provided by Dr L. A. Aarden. 8 TNF was assayed using L929 fibroblasts, using a protocol adapted from Matthews and Neale. 39 (Fig. 3) When rats were pretreated with Dex (0.5 mg/kg, s.c.) 1 h before the harvesting of the peritoneal macrophages and all further steps of the supernatant preparation were conducted in presence of 9 t.tg/ml Dex, the magnitude of fever induced by the resulting supernatant was similar to that induced by supernatant from macrophages obtained from untreated animals (Fig. 4) (Fig. 6) . The 
Discussion
This study shows that macrophages briefly stimulated with LPS release a factor that induces an increase in rectal temperature, neutrophilia and reduction in serum Fe and Zn levels, mimicking important components of APR. It is unlikely that these activities represent a nonspecific response due to contamination of the supernatant with LPS since when the metabolic activity of the macrophages was reduced by cooling to 4C, they did not release pyrogenic factor(s), and boiling the supernatant abolished the fever and Zn reduction and reduced the neutrophilia. The release of the pyrogenic factor(s) was not related to previous thioglycollate stimulation, since supernatant from LPS-stimulated resident macrophages also induced fever.
The treatment of the cells, or rats acting as the source of macrophages, with Dex did not modify the pyrogenic activity, although production of IL-1, IL-6 and TNF was inhibited. Since glucocorticoids suppress the cytokine or LPS-stimulated production of IL-1, 41 WNF, 42 The failure of Chx to inhibit the release of the factor that induces fever and reduction of the serum metal levels supports the hypothesis that this factor is not produced following synthesis of cytokines, though it did abolish the release of the factor that induced neutrophilia. Moore et al. 44 and Nordlund et al. 45 showed that Chx inhibits the production of EP by rabbit Kluger has stressed that although many cytokines induce fever when injected into experimental animals or humans, the precise contribution of any EP in naturally occurring fever has not yet been completely determined. This concept, together with evidence for a pre-formed pyrogenic factor described here, allow us to hypothesize that this factor may represent a trigger for fever induction by promoting the release of another pyrogenic mediator which acts by a prostaglandin independent mechanism. A possible candidate is CRF, explaining the effectiveness of glucocorticoids and the partial effectiveness of cyclooxgynase inhibitors in the febrile response induced in rats by IL-113 or LPS. These findings could explain the inability of antipyretic drugs to abrogate the fever response observed in a number of clinical situations. Furthermore, the present study emphasizes the importance of macrophages as alarm cells 55 because of their ability to react to foreign substances and release mediators responsible for the initial systemic and local events, such as fever, neutrophilia and cell migration. 3, 56 In conclusion, the results presented here allow us to suggest that macrophages contain pre-formed pyrogenic substance(s) which are not related to ILl[3, IL-6 or TNF, and act indirectly and independently of prostaglandin synthesis. It also seems likely that the pyrogenic activity is related to the factor responsible for the reduction of serum Fe and Zn levels, but not the neutrophilia.
